URS
NTLA icon

Utah Retirement Systems’s Intellia Therapeutics NTLA Stock Holding History

Utah Retirement Systems’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,400
Closed -$328K – 990
2022
Q4 		$328K Hold
9,400
– – 0.01% 849
2022
Q3 		$526K Hold
9,400
– – 0.01% 809
2022
Q2 		$487K Buy
9,400
+600
+7% +$30.5K 0.01% 821
2022
Q1 		$639K Hold
8,800
– – 0.01% 821
2021
Q4 		$1.04M Hold
8,800
– – 0.01% 764
2021
Q3 		$1.18M Buy
+8,800
New +$1.33M 0.02% 742

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Utah Retirement Systems's NTLA Position: Q1 2023 in Review

Utah Retirement Systems sold out of Intellia Therapeutics (NTLA) in Q1 2023, closing a stake of 9,400 shares — an estimated $328K sold.

Utah Retirement Systems first reported a position in NTLA in Q3 2021 and held it in 6 quarters. The position peaked at $1.18M in Q3 2021. 290 funds tracked by Wall St. Rank hold NTLA as of Q1 2023.

  • Utah Retirement Systems reported no remaining Intellia Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Utah Retirement Systems sold 9,400 Intellia Therapeutics shares in Q1 2023, an estimated $328K.
  • Utah Retirement Systems first reported a position in Intellia Therapeutics in Q3 2021 and held it in 6 quarters.
  • Utah Retirement Systems's Intellia Therapeutics position peaked at $1.18M in Q3 2021.
  • 290 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2023.

Based on Utah Retirement Systems's 13F filing for Q1 2023, filed 16 May 2023.